Goldman Sachs’s Intuitive Surgical ISRG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.38M | Buy |
16,000
+1,000
| +7% | +$506K | ﹤0.01% | 3326 |
|
|
2025
Q4 | $8.5M | Hold |
15,000
| – | – | ﹤0.01% | 3255 |
|
|
2025
Q3 | $6.71M | Sell |
15,000
-17,100
| -53% | -$8.21M | ﹤0.01% | 3374 |
|
|
2025
Q2 | $17.4M | Buy |
32,100
+5,100
| +19% | +$2.67M | ﹤0.01% | 2249 |
|
|
2025
Q1 | $13.4M | Buy |
27,000
+20,000
| +286% | +$11.1M | ﹤0.01% | 2421 |
|
|
2024
Q4 | $3.65M | Buy |
+7,000
| New | +$3.65M | ﹤0.01% | 3769 |
|
|
2024
Q1 | – | Sell |
-10,000
| Closed | -$3.37M | – | 5716 |
|
|
2023
Q4 | $3.37M | Sell |
10,000
-27,500
| -73% | -$8.2M | ﹤0.01% | 3498 |
|
|
2023
Q3 | $11M | Sell |
37,500
-62,500
| -63% | -$19.5M | ﹤0.01% | 2309 |
|
|
2023
Q2 | $34.2M | Buy |
100,000
+20,400
| +26% | +$6.17M | 0.01% | 1383 |
|
|
2023
Q1 | $20.3M | Buy |
+79,600
| New | +$19.6M | ﹤0.01% | 1811 |
|
|
2022
Q4 | – | Sell |
-103,600
| Closed | -$19.4M | – | 6133 |
|
|
2022
Q3 | $19.4M | Buy |
+103,600
| New | +$22.3M | ﹤0.01% | 1893 |
|
|
2021
Q4 | – | Sell |
-1,500
| Closed | -$497K | – | 6567 |
|
|
2021
Q3 | $497K | Sell |
1,500
-11,700
| -89% | -$3.93M | ﹤0.01% | 5197 |
|
|
2021
Q2 | $4.05M | Sell |
13,200
-8,400
| -39% | -$2.36M | ﹤0.01% | 3540 |
|
|
2021
Q1 | $5.32M | Sell |
21,600
-11,100
| -34% | -$2.79M | ﹤0.01% | 3085 |
|
|
2020
Q4 | $8.92M | Sell |
32,700
-22,800
| -41% | -$5.66M | ﹤0.01% | 2562 |
|
|
2020
Q3 | $13.1M | Buy |
55,500
+12,900
| +30% | +$2.9M | ﹤0.01% | 2078 |
|
|
2020
Q2 | $8.09M | Sell |
42,600
-23,400
| -35% | -$4.19M | ﹤0.01% | 2425 |
|
|
2020
Q1 | $10.9M | Buy |
66,000
+43,800
| +197% | +$8.02M | ﹤0.01% | 2030 |
|
|
2019
Q4 | $4.38M | Buy |
22,200
+16,500
| +289% | +$3.09M | ﹤0.01% | 3061 |
|
|
2019
Q3 | $1.03M | Sell |
5,700
-22,800
| -80% | -$3.94M | ﹤0.01% | 4013 |
|
|
2019
Q2 | $4.98M | Buy |
28,500
+13,200
| +86% | +$2.26M | ﹤0.01% | 2845 |
|
|
2019
Q1 | $2.91M | Sell |
15,300
-75,300
| -83% | -$13.4M | ﹤0.01% | 3354 |
|
|
2018
Q4 | $14.5M | Buy |
90,600
+60,000
| +196% | +$10.2M | ﹤0.01% | 2059 |
|
|
2018
Q3 | $5.86M | Sell |
30,600
-15,000
| -33% | -$2.66M | ﹤0.01% | 2866 |
|
|
2018
Q2 | $7.27M | Buy |
45,600
+9,300
| +26% | +$1.42M | ﹤0.01% | 2675 |
|
|
2018
Q1 | $5M | Sell |
36,300
-84,900
| -70% | -$11.8M | ﹤0.01% | 2885 |
|
|
2017
Q4 | $14.7M | Sell |
121,200
-50,700
| -29% | -$6.35M | ﹤0.01% | 2168 |
|
|
2017
Q3 | $20M | Sell |
171,900
-95,400
| -36% | -$10.4M | ﹤0.01% | 1990 |
|
|
2017
Q2 | $27.8M | Sell |
267,300
-34,200
| -11% | -$3.29M | 0.01% | 1676 |
|
|
2017
Q1 | $25.7M | Sell |
301,500
-459,000
| -60% | -$36.3M | 0.01% | 1721 |
|
|
2016
Q4 | $53.6M | Buy |
760,500
+76,500
| +11% | +$5.62M | 0.02% | 1215 |
|
|
2016
Q3 | $55.1M | Buy |
684,000
+442,800
| +184% | +$33.9M | 0.02% | 1124 |
|
|
2016
Q2 | $17.7M | Sell |
241,200
-160,200
| -40% | -$11.3M | 0.01% | 1877 |
|
|
2016
Q1 | $26.8M | Buy |
401,400
+142,200
| +55% | +$8.81M | 0.01% | 1504 |
|
|
2015
Q4 | $15.7M | Sell |
259,200
-333,900
| -56% | -$18.8M | ﹤0.01% | 1929 |
|
|
2015
Q3 | $30.3M | Buy |
593,100
+73,800
| +14% | +$4.18M | 0.01% | 1406 |
|
|
2015
Q2 | $28M | Buy |
519,300
+241,200
| +87% | +$13.5M | 0.01% | 1551 |
|
|
2015
Q1 | $15.6M | Sell |
278,100
-392,400
| -59% | -$22.2M | 0.01% | 1935 |
|
|
2014
Q4 | $39.4M | Buy |
670,500
+33,300
| +5% | +$1.85M | 0.01% | 1297 |
|
|
2014
Q3 | $32.7M | Sell |
637,200
-3,339,000
| -84% | -$166M | 0.01% | 1410 |
|
|
2014
Q2 | $182M | Buy |
3,976,200
+2,764,800
| +228% | +$122M | 0.06% | 396 |
|
|
2014
Q1 | $59M | Sell |
1,211,400
-572,400
| -32% | -$27M | 0.02% | 930 |
|
|
2013
Q4 | $76.1M | Buy |
1,783,800
+36,900
| +2% | +$1.55M | 0.03% | 774 |
|
|
2013
Q3 | $73M | Buy |
1,746,900
+714,600
| +69% | +$31.6M | 0.03% | 733 |
|
|
2013
Q2 | $58.1M | Buy |
+1,032,300
| New | +$56.9M | 0.02% | 820 |
|
Other funds holding ISRG
VCM
VPM
Goldman Sachs's ISRG Position: Q1 2026 in Review
Goldman Sachs increased its Intuitive Surgical (ISRG) stake by 1.4% in Q1 2026, buying an estimated $16.9M and bringing the position to 2,451,269 shares worth $1.13B. The position accounts for 0.13% of the portfolio, ranked #138.
Goldman Sachs first reported a position in ISRG in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.4B in Q3 2025. 2,302 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.
- Goldman Sachs held 2,451,269 shares of Intuitive Surgical worth $1.13B as of Q1 2026.
- Goldman Sachs bought 33,473 Intuitive Surgical shares in Q1 2026, an estimated $16.9M.
- Intuitive Surgical made up 0.13% of Goldman Sachs's portfolio in Q1 2026, its #138 holding.
- Goldman Sachs first reported a position in Intuitive Surgical in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Intuitive Surgical position peaked at $1.4B in Q3 2025.
- 2,302 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.